Evicenter
MarkdownMedical informationP&T meetings
Barzolvolimab (CDX-0159)

Chronic spontaneous urticaria

Launch
Not announced
Last updated
177 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Mechanism of action

10 evidence topics · 8 sources

Humanized monoclonal antibody that binds KIT and blocks SCF binding and KIT dimerization
Allosteric inhibition through the membrane-proximal dimerization domains of KIT
Fc substitutions that abolish effector function and reduce clearance